Back to search

Article

Pseudoirreversible inhibition elicits persistent efficacy of a sphigosine-1-phosphate receptor-1 antagonist

2023-05-09

Abstract excerpt

<h4>ABSTRACT</h4> Sphingosine 1-phosphate receptor 1 (S1PR1), a G protein-coupled receptor, is required for lymphocyte trafficking, and is a promising therapeutic target in inflammatory diseases. We synthesized a competitive antagonist, KSI-6666, that persistently inhibits S1PR1 activity and effectively suppresses pathogenic inflammation. Metadynamics simulation proposed that the interaction of KSI-6666 with a me...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e0080d30-1e7b-5199-9866-3c89d0843bd4
DOI
10.1101/2023.05.08.539826
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pseudoirreversible inhibition elicits persistent efficacy of a sphigosine-1-phosphate receptor-1 antagonistDOI 10.1101/2023.05.08.539826
Select a neighboring publication to make it the new centre.